| Factor Information | |
|---|---|
| Data ID | 3102 |
| Factor | percentage of abnormal screening in worst case scenario |
| Description | N/A |
| Biomarker | NA |
| Classification | A4 (clinical factor - examination) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | The purpose of this study was to determine the relative importance of the 4-chamber view (4CV) compared with the outflow tract views (OFTVs) in prenatal screening for major congenital heart disease (CHD). |
| p Value | <0.001 |
| Conclusion | Congenital heart disease that would be expected to have abnormal screening OFTVs was more common than CHD that would be expected to have an abnormal screening 4CV in both the best case scenario (91% versus 63%; P < .001) and worst case scenario (63% versus 31%; P < .001). |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 651 |
| CHD Type | isolated CHD/non-isolated CHD |
| CHD Subtype | TOF/CoA/TGA/HLHS/VSD/AVC/TOF, APV/PA, IVS/EA, TVD/DORV/TAPVR/BAVC/UAVC/PS/AS, AA/IAA/PA, IVS/SV |
| Reference | |
|---|---|
| PMID | 19546331 |
| Year | 2009 |
| Title | Prenatal Screening for Major Congenital Heart Disease |
| Sample | ||
|---|---|---|
| Population | infants | |
| Source | patients' data | |
| Region | California, America | |
| Method | χ2 statistics | |
| Race | American | |
| Disease History | N/A | |
| Treatment History | prenatal screening | |
| Group | abnormal screening OFTVs(Treatment) | abnormal screening 4CV(Control) |
| Number | 46 | 53 |
| Age | N/A | N/A |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 0.63 | 0.31 |
